Device type · QLT
Covid-19 Multi-Analyte Respiratory Panel Nucleic Acid Devices
Last checked: Nov 20, 2026Source: openFDAMethods & limitations
Product code
QLT
Microbiology
Device class
Not classified
FDA decisions since 2015
0
510(k), De Novo and PMA
Adverse event reports
1
Received Nov 1, 2025 to Nov 20, 2026
How FDA classifies it
- Device type
- Covid-19 Multi-Analyte Respiratory Panel Nucleic Acid Devices
- Product code
- QLT
- Device class
- Not classified
- Review panel
- Microbiology
- Specialty
- Laboratory Medicine & Pathology
- FDA record
- Classification database entry for QLT
Latest FDA decisions
No 510(k), De Novo or PMA decisions for this product code since 2015.
Reports received
1
Received Nov 1, 2025 to Nov 20, 2026
Malfunction reports
1
100% of reports
Injury reports
0
0.0% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 12 | 1 | 0 | 0 |
| Jan 24 | 28 | 0 | 0 | 0 |
| Feb 24 | 25 | 0 | 0 | 0 |
| Mar 24 | 21 | 0 | 0 | 0 |
| Apr 24 | 29 | 0 | 0 | 0 |
| May 24 | 3 | 0 | 0 | 0 |
| Jun 24 | 1 | 0 | 0 | 0 |
| Jul 24 | 2 | 0 | 0 | 0 |
| Aug 24 | 1 | 1 | 0 | 0 |
| Sep 24 | 2 | 0 | 0 | 0 |
| Oct 24 | 0 | 0 | 0 | 0 |
| Nov 24 | 1 | 0 | 0 | 0 |
| Dec 24 | 1 | 0 | 0 | 0 |
| Jan 25 | 0 | 0 | 0 | 0 |
| Feb 25 | 0 | 0 | 0 | 0 |
| Mar 25 | 1 | 0 | 0 | 0 |
| Apr 25 | 1 | 0 | 0 | 0 |
| May 25 | 0 | 0 | 0 | 0 |
| Jun 25 | 0 | 0 | 0 | 0 |
| Jul 25 | 0 | 0 | 0 | 0 |
| Aug 25 | 0 | 0 | 0 | 0 |
| Sep 25 | 0 | 0 | 0 | 0 |
| Oct 25 | 0 | 0 | 0 | 0 |
| Nov 25 | 0 | 0 | 0 | 0 |
| Dec 25 | 0 | 0 | 0 | 0 |
| Jan 26 | 0 | 0 | 0 | 0 |
| Feb 26 | 0 | 0 | 0 | 0 |
| Mar 26 | 0 | 0 | 0 | 0 |
| Apr 26 | 1 | 0 | 0 | 0 |
| May 26 | 0 | 0 | 0 | 0 |
| Jun 26 | 0 | 0 | 0 | 0 |
| Jul 26 | 0 | 0 | 0 | 0 |
| Aug 26 | 0 | 0 | 0 | 0 |
| Sep 26 | 0 | 0 | 0 | 0 |
| Oct 26 | 0 | 0 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- False Negative Result1
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions1
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- NxTAG Respiratory Pathogen Panel +SARS-CoV-2, REF: I056C0468Open, Classified
Luminex Molecular Diagnostics Inc
Z-0043-2025 · Started Sep 5, 2024 · Posted by FDA Oct 9, 2024
Reason given: Respiratory pathogen panel may report an elevated rate (7.6% predicted probability of occurrence) of non-specific hMPV target (human Metapneumovirus) results, risk identified predominantly in clinical samples that present positivity for another target, leading to an erroneous co-infection result, can potentially...
Cause as FDA categorized it: Device Design
10 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.